Counteracting the enzymatic activity of dipeptidylpeptidase 4 for potential therapeutic advantage, with an emphasis on cord blood transplantation
Hal E. Broxmeyer
Korean J Intern Med. 2013;28(6):639-645. Published online 2013 Oct 29 DOI: https://doi.org/10.3904/kjim.2013.28.6.639
Citations to this article as recorded by 
What doesn't kill you makes you stranger: Dipeptidyl peptidase-4 (CD26) proteolysis differentially modulates the activity of many peptide hormones and cytokines generating novel cryptic bioactive ligands
Ahmed M. Elmansi, Mohamed E. Awad, Nada H. Eisa, Dmitry Kondrikov, Khaled A. Hussein, Alexandra Aguilar-Pérez, Samuel Herberg, Sudharsan Periyasamy-Thandavan, Sadanand Fulzele, Mark W. Hamrick, Meghan E. McGee-Lawrence, Carlos M. Isales, Brian F. Volkman,
Pharmacology & Therapeutics.2019; 198: 90. CrossRef
The perceptions of natural compounds against dipeptidyl peptidase 4 in diabetes: from in silico to in vivo
Shian-Ren Lin, Chia-Hsiang Chang, May-Jwan Tsai, Henrich Cheng, Jian-Chyi Chen, Max K. Leong, Ching-Feng Weng
Therapeutic Advances in Chronic Disease.2019;[Epub] CrossRef